Qkine
High quality and novel growth factors for stem cell and organoid culture, regenerative medicine and cellular agriculture
Founded 2016
Cambridge, United Kingdom
40 employees
Series B
Total: $6.37M
Biotechnology, Life Sciences
Cambridge, United Kingdom
40 employees
Series B
Total: $6.37M
Biotechnology, Life Sciences
General Information
Get notified when Qkine moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Discover More
United Kingdom Market
Biotechnology
About Qkine
Taxonomy: Biologically active proteins, Protein purification, Stem cell culture, Regenerative medicine, Cellular agriculture, Animal-free growth factors, Organoid culture, Protein engineering, ISO 9001:2015 certified, Thermostable FGF-2, TGF beta 1 for stem cell media, HGF (NK1), Cambridge Science Park, Research and development, Recombinant proteins
Services & Products
Manufacturing bioactive proteins
Developing unique optimized proteins
Sustainable protein production
Target Customers
Research institutions
Biotechnology companies
Pharmaceutical companies
Academic laboratories
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 4 |
|
15 Dec 2022 |
| Series A | •••••• | 5 |
|
08 Jun 2020 |
| Seed Round | •••••• | 1 | •••• •••• | 03 Jun 2019 |
| Grant | •••••• | - | 12 Jul 2018 | |
| Seed Round | •••••• | - | 02 May 2018 |
Qkine Alternatives & Competitors
Qkine vs
StemImmune LLC
United States
Humanized cytokines and Growth factors for your research and preclinical study. Save your money and...
3 employees
Biopharma, Biotechnology
Qkine vs
ScienCell Research Laboratories
United States
Helping the Scientists of Today Discover the Science of Tomorrow
49 employees
Biotechnology, Clean Energy
Qkine vs
Laurus Bio
India
We harness the power of precision fermentation and biomanufacturing to enable a safe and sustainable...
395 employees
Biotechnology, Manufacturing
FAQ About Qkine
High quality and novel growth factors for stem cell and organoid culture, regenerative medicine and cellular agriculture
Qkine was founded in 2016.
Qkine is headquartered in Cambridge, United Kingdom.
Qkine operates in the following industries: Biotechnology, Life Sciences.
Qkine has approximately 40 employees.
Qkine has completed 5 funding rounds, raising a total of $6.37M. The latest funding stage is Series B.
Qkine offers: Manufacturing bioactive proteins, Developing unique optimized proteins, Sustainable protein production.
Top alternatives and competitors to Qkine include StemImmune LLC, ScienCell Research Laboratories, Laurus Bio , trenzyme GmbH, Wuhan Healthgen Biotechnology Corp.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Qkine and StemImmune LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Qkine and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.